Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 20 of 40

News

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

19.12.2022

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic

News

EMCDDA participates in Latin American regional meeting on early warning systems

09.12.2022

This week, the EMCDDA participated in a meeting ‘Early warning systems in response to opioids and new psychoactive substances’, organised by the Inter-Ame

News

No laughing matter - new report shows rise in recreational use of nitrous oxide

21.11.2022

A rise in the supply and recreational use of nitrous oxide (‘laughing gas’) is the focus of a new report out today from the EU drugs agency (EMCDDA).

News

Meeting with Panamanian authorities on early-warning system and new psychoactive substances (NPS)

28.10.2022

On 25 October, an EMCDDA team met with members of the Panamanian National Commission for the Study and Prevention of Drug-Related Crimes (CONAPRED) in Panana City.

News

25 years of monitoring and responding to new drugs in Europe — update published today

14.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

Drug supply and use bounce back after COVID-19 disruption

14.06.2022

The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022: Trends and Developments (

News

25 years of early warning and response to new psychoactive substances in Europe

07.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply

18.03.2022

Today, the European Commission has adopted measures to control two harmful new psychoactive substances (NPS) across the EU (1). The substances in question —

News

European Commissioner Johansson and EMCDDA Director Goosdeel visit Belgian National Institute of Criminalistics and Criminology

06.12.2021

European Commissioner for Home Affairs, Ylva Johansson will visit the Belgian National Institute of Criminalistics and Criminology (NICC), in Brussels today, accompanied by Alexis Goosdeel, Director of the European Monitoring Centre for Drugs and Drug

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA).

News

New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

09.06.2021

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1).

News

European Commission proposes to control two harmful new psychoactive substances

12.03.2021

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe (1).

News

EMCDDA preparedness and response to a fast-moving drugs problem

30.04.2020

Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with new developments and rethink existing routines.

News

New legislation, bringing faster response to new drugs, applies from today

23.11.2018

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) will be significantly strengthened, thanks to new legislation applying from today (1).

News

Two new synthetic opioids to be placed under control across the EU

28.09.2018

Today, the European Union has decided to subject two new synthetic opioids to control measures across the 28 Member States.

News

EMCDDA publishes latest insights into NPS in Europe

07.06.2018

In a new update from the EU Early Warning System (EWS) on new psychoactive substances (NPS) (1), the EMCDDA releases today its latest insights in this area entitled Fentanils and synthetic c

News

Two new synthetic cannabinoids to be placed under control across the EU

14.05.2018

Today the European Union has decided to subject two new synthetic cannabinoids to control measures across the 28 Member States. The substances in question are ADB-CHMINACA and CUMYL-4CN-BINACA, which have been raising health concerns in Europe.

News

New legislation published today to bring faster response to new drugs

21.11.2017

Europe’s ability to rapidly respond to public health and security threats caused by new psychoactive substances will be significantly strengthened, thanks to new legislation published today by the European Union.

News

Furanylfentanyl to be placed under control across the EU

15.11.2017

Today the European Union has decided to subject the new synthetic opioid furanylfentanyl to control measures throughout the EU.

News

Acryloylfentanyl to be placed under control across the EU

29.09.2017

This week, the EU has reacted to serious concerns over the use of the synthetic opioid acryloylfentanyl by deciding to subject it to ‘control measures’ throughout the Union.
Loading